Serum uric acid and related factors in 500 hospitalized subjects

被引:59
作者
Saggiani, F
Pilati, S
Targher, G
Branzi, P
Muggeo, M
Bonora, E
机构
[1] UNIV VERONA, DIV ENDOCRINOL & METAB DIS, I-37100 VERONA, ITALY
[2] HOSP MANTUA, DIV INTERNAL MED 1, MANTUA, ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1996年 / 45卷 / 12期
关键词
D O I
10.1016/S0026-0495(96)90188-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study purpose was to determine the following in a large sample of hospitalized patients: (1) the prevalence of hyperuricemia, (2) the association of hyperuricemia with other metabolic disorders, and (3) the factors independently predicting hyperuricemia. Five hundred adult patients (250 men and 250 women) were randomly selected from those admitted as inpatients over a period of 5 months. In all patients, body mass index (BMI), blood pressure, and serum glucose, lipid, creatinine, urea nitrogen, and urate concentrations were measured. The presence of diseases or use of medications known to affect serum urate levels were recorded. The mean level of serum urate was 5.6 mg/dL in the whole sample, 6.0 mg/dL in men and 5.3 mg/dL in women (P = .003, men v women). The prevalence of hyperuricemia was 27.6% (28.8% and 26.4% in men v women, P = nonsignificant). A definite or probable secondary hyperuricemia was found in 87.7% of the subjects. Hyperuricemia was rarely isolated (21%), whereas it was frequently associated with hypertension (60.1%), hyperlipidemia (31.2%), diabetes (28.3%), and obesity (21.7%). In 26.8% of the subjects, hyperuricemia was associated with two metabolic disorders, in 13.8% with three, and in 2.9% with four. Multiple metabolic disorders (three to four) were found in 16.7% of subjects with hyperuricemia. Serum urate levels progressively increased across a range of subjects from those without diabetes, hyperlipidemia, hypertension, or obesity to those with one, two, or a greater number of associated metabolic abnormalities. Multiple stepwise regression analysis showed that 43% of serum urate variability was explained by urea nitrogen levels, triglyceride levels, diuretic therapy, the inverse of creatinine (as an index linearly related to creatinine clearance), and BMI. These results indicate that in hospitalized subjects, hyperuricemia is (1) frequent, (2) a secondary phenomenon in most cases, and (3) frequently associated with other metabolic disorders. The major predictors of high serum urate levels are BMI, triglycerides, parameters of renal function, and use of diuretics. These variables explain a large proportion of serum urate variability. Copyright (C) 1996 by W.B. Saunders Company
引用
收藏
页码:1557 / 1561
页数:5
相关论文
共 41 条
[1]  
Berkowitz D., 1966, JAMA-J AM MED ASSOC, V197, P117
[2]  
BONSNES RW, 1945, J BIOL CHEM, V158, P581
[3]   HYPER-URICEMIA AND GOUT - CLASSIFICATION, COMPLICATIONS AND MANAGEMENT [J].
BOSS, GR ;
SEEGMILLER, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (26) :1459-1468
[4]   HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[5]  
BRAY GA, 1992, OBESITY, P294
[6]  
CIGOLINI M, 1995, INT J OBESITY, V19, P92
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]  
DENNIS VW, 1988, CECIL TXB MED, P494
[9]   RELATIONSHIP BETWEEN RESISTANCE TO INSULIN-MEDIATED GLUCOSE-UPTAKE, URINARY URIC-ACID CLEARANCE, AND PLASMA URIC-ACID CONCENTRATION [J].
FACCHINI, F ;
CHEN, YDI ;
HOLLENBECK, CB ;
REAVEN, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :3008-3011
[10]   HYPERINSULINEMIA - THE KEY FEATURE OF A CARDIOVASCULAR AND METABOLIC SYNDROME [J].
FERRANNINI, E ;
HAFFNER, SM ;
MITCHELL, BD ;
STERN, MP .
DIABETOLOGIA, 1991, 34 (06) :416-422